Article
Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan
12 Sept 2011
Abstract excerpt
BACKGROUND: Pyrazinamide (PZA) is an important first-line drug in multidrug-resistant tuberculosis (MDRTB) treatment. However, the unreliable results obtained from traditional susceptibility testing limits its usefulness in clinical settings. The detection of pncA gene mutations is a potential surrogate of PZA susceptibility testing, especially in MDRTB isolates. The impact of genotypes of M. tuberculosis in pncA...
Topics
Join the communities discussing this publication.
